13F-HR filed by B Group, Inc.
B Group, Inc. filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 17 holding rows worth $129,935,291.
- Accession
- 0001420506-25-002005
- Filer
- CIK 2043476
- Filed
- 2025-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 17 entries on the cover page, a total value of $129,935,291 stated on the cover page (in dollars after the unit check, H1), rows summing to $129,935,291 with VALUE read as dollars as filed, 13F file number 028-25141. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ADMA BIOLOGICS INC | 000899104 | COM | 2,317,542 | $42,202,440 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 155,000 | $15,599,200 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 400,000 | $13,988,000 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 232,446 | $12,403,319 | dollars as filed | |
| ELI LILLY & CO | 532457958 | PUT | 15,000 | $11,692,950 | dollars as filed | put |
| CELLECTIS ADS | 15117K103 | COM | 3,256,501 | $4,966,164 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 1,800,556 | $4,159,284 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 110,000 | $3,999,600 | dollars as filed | |
| SIGHT SCIENCES INC | 82657M105 | COMMON STOCK | 930,000 | $3,840,900 | dollars as filed | |
| AURA BIOSCIENCES INC | 05153U107 | COMMON STOCK | 572,576 | $3,584,326 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 189,350 | $3,431,022 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,500,000 | $2,580,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D908 | CALL | 67,600 | $2,457,936 | dollars as filed | call |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 35,000 | $1,520,050 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 35,000 | $1,471,750 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 80,000 | $1,197,600 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 75,000 | $840,750 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-25-002005 | this filing | 2025-08-14 | acceptance time not in the bulk data set |